These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
543 related items for PubMed ID: 31185140
1. Benefits of curcumin in brain disorders. Bhat A, Mahalakshmi AM, Ray B, Tuladhar S, Hediyal TA, Manthiannem E, Padamati J, Chandra R, Chidambaram SB, Sakharkar MK. Biofactors; 2019 Sep; 45(5):666-689. PubMed ID: 31185140 [Abstract] [Full Text] [Related]
2. Curcumin Therapeutic Modulation of the Wnt Signaling Pathway. Ashrafizadeh M, Ahmadi Z, Mohamamdinejad R, Yaribeygi H, Serban MC, Orafai HM, Sahebkar A. Curr Pharm Biotechnol; 2020 Sep; 21(11):1006-1015. PubMed ID: 32133961 [Abstract] [Full Text] [Related]
6. A Review of the Common Neurodegenerative Disorders: Current Therapeutic Approaches and the Potential Role of Bioactive Peptides. Singh K, Gupta JK, Kumar S, Soni U. Curr Protein Pept Sci; 2024 Mar; 25(7):507-526. PubMed ID: 38561605 [Abstract] [Full Text] [Related]
7. The Renin-Angiotensin System and the Neurodegenerative Diseases: A Brief Review. Almeida-Santos AF, Kangussu LM, Campagnole-Santos MJ. Protein Pept Lett; 2017 Nov 17; 24(9):841-853. PubMed ID: 28828974 [Abstract] [Full Text] [Related]
9. Mitochondrial Dysfunctions: A Red Thread across Neurodegenerative Diseases. Stanga S, Caretto A, Boido M, Vercelli A. Int J Mol Sci; 2020 May 25; 21(10):. PubMed ID: 32466216 [Abstract] [Full Text] [Related]
11. Curcumin: a potential neuroprotective agent in Parkinson's disease. Mythri RB, Bharath MM. Curr Pharm Des; 2012 May 25; 18(1):91-9. PubMed ID: 22211691 [Abstract] [Full Text] [Related]
12. PPARγ as a therapeutic target to rescue mitochondrial function in neurological disease. Corona JC, Duchen MR. Free Radic Biol Med; 2016 Nov 25; 100():153-163. PubMed ID: 27352979 [Abstract] [Full Text] [Related]
13. Novel Drug Delivery System for Curcumin: Implementation to Improve Therapeutic Efficacy against Neurological Disorders. Mohi-Ud-Din R, Mir RH, Wani TU, Shah AJ, Mohi-Ud-Din I, Dar MA, Pottoo FH. Comb Chem High Throughput Screen; 2022 Nov 25; 25(4):607-615. PubMed ID: 34225614 [Abstract] [Full Text] [Related]
14. Role of curcumin and its nanoformulations in neurotherapeutics: A comprehensive review. Mandal M, Jaiswal P, Mishra A. J Biochem Mol Toxicol; 2020 Jun 25; 34(6):e22478. PubMed ID: 32124518 [Abstract] [Full Text] [Related]
15. Neuroprotective and anti-inflammatory effects of curcumin in Alzheimer's disease: Targeting neuroinflammation strategies. Azzini E, Peña-Corona SI, Hernández-Parra H, Chandran D, Saleena LAK, Sawikr Y, Peluso I, Dhumal S, Kumar M, Leyva-Gómez G, Martorell M, Sharifi-Rad J, Calina D. Phytother Res; 2024 Jun 25; 38(6):3169-3189. PubMed ID: 38616356 [Abstract] [Full Text] [Related]
16. Exploring the potential of natural and synthetic neuroprotective steroids against neurodegenerative disorders: A literature review. Bansal R, Singh R. Med Res Rev; 2018 Jul 25; 38(4):1126-1158. PubMed ID: 28697282 [Abstract] [Full Text] [Related]
17. Antioxidants in central nervous system diseases: preclinical promise and translational challenges. Kamat CD, Gadal S, Mhatre M, Williamson KS, Pye QN, Hensley K. J Alzheimers Dis; 2008 Nov 25; 15(3):473-93. PubMed ID: 18997301 [Abstract] [Full Text] [Related]
18. [Neuroprotective effects of curcumin]. Li Y, Wang P. Zhongguo Zhong Yao Za Zhi; 2009 Dec 25; 34(24):3173-5. PubMed ID: 20352992 [Abstract] [Full Text] [Related]
19. Digging Deeper: Advancements in Visualization of Inhibitory Synapses in Neurodegenerative Disorders. Radulović S, Sunkara S, Maurer C, Leitinger G. Int J Mol Sci; 2021 Nov 18; 22(22):. PubMed ID: 34830352 [Abstract] [Full Text] [Related]
20. The kynurenine pathway in neurodegenerative diseases: mechanistic and therapeutic considerations. Tan L, Yu JT, Tan L. J Neurol Sci; 2012 Dec 15; 323(1-2):1-8. PubMed ID: 22939820 [Abstract] [Full Text] [Related] Page: [Next] [New Search]